Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Murray, Utah 25 trials found
New Search
Filter
Trial Phase
Study Type
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
PHASE1INTERVENTIONAL Springdale, Arkansas +4 more
RECRUITING
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
PHASE1, PHASE2INTERVENTIONAL La Jolla, California +4 more
RECRUITING
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
PHASE1INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
PHASE1INTERVENTIONAL Rochester, Minnesota +4 more
RECRUITING
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).
PHASE1, PHASE2INTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
PHASE1, PHASE2INTERVENTIONAL La Jolla, California +4 more
RECRUITING
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
PHASE1, PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
PHASE1INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Study of MGC026 in Participants With Advanced Solid Tumors
PHASE1INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
PHASE1INTERVENTIONAL Newport Beach, California +4 more
RECRUITING
First-in-human Study of 7MW4911 in GI Cancer
PHASE1, PHASE2INTERVENTIONAL Port Saint Lucie, Florida +4 more
RECRUITING
A Phase 1/1b Study of IAM1363 in HER2 Cancers
PHASE1INTERVENTIONAL La Jolla, California +4 more
RECRUITING
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Pembro With Radiation With or Without Olaparib
PHASE2INTERVENTIONAL Lexington, Kentucky +1 more
RECRUITING
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
PHASE2INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
PHASE2INTERVENTIONAL Duarte, California +2 more
RECRUITING
Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy
PHASE1INTERVENTIONAL Salt Lake City, Utah
RECRUITING
Filter Trials
Trial Phase
Study Type